Interaction of hallucinogenic drugs with encephalitogenic protein of myelin.
D001667:Binding, Competitive; D003429:Cross Reactions; D000939:Epitopes; D006213:Hallucinogens; D006801:Humans; D007211:Indoles; D008214:Lymphocytes / Q000276:immunology; D008238:Lysergic Acid Diethylamide; D009103:Multiple Sclerosis / Q000276:immunology; D004676:Myelin Basic Protein; D009419:Nerve Tissue Proteins; D009422:Nervous System Diseases / Q000276:immunology; D011955:Receptors, Drug; D012701:Serotonin; D014363:Tryptamines
D000939:Epitopes; D006213:Hallucinogens; D007211:Indoles; D004676:Myelin Basic Protein; D009419:Nerve Tissue Proteins; D011955:Receptors, Drug; D014363:Tryptamines; D012701:Serotonin; D008238:Lysergic Acid Diethylamide